• INJ holds support between $9.00 and $12.97, maintaining structure despite recent declines.

  • Upside targets at $16.12 and $32.75 remain valid if current levels hold.

  • Volume remains low, which limits the strength of the ongoing recovery.

Injective (INJ) has returned to a key weekly support zone after weeks of corrective movement. It is currently trading at $10.67 with a 2.0% gain over the last 24 hours. The price action is centered around the support level of $10.29 and has been a traditional zone of reversal as well as consolidation. Volume has continued staying calm as the market assesses the next directional cycle.

INJ Holds Structural Base as Weekly Range Tightens

The weekly chart displays a strong structural base forming between the $9.00 and $12.97 range. Multiple tests of this support zone have occurred, most recently in July 2025. Notably, the asset bounced from the $10.38 area, holding above immediate support. This level continues to serve as the threshold for potential upside. If prices remain above this yellow zone, further movement toward resistance levels remains on the table.

https://twitter.com/best_analysts/status/1942807522798129280

Upside targets currently include $12.97 and $16.12, both marked by prior structural resistance. Above these, the broader zone between $32.75 and $43.09 represents the next key range. These levels align with former distribution zones from 2024 and may act as checkpoints during any extended rally. Weekly candles continue to form within the base range, suggesting the consolidation phase may not yet be complete.

INJ Price Compression Persists as Market Awaits Breakout 

While momentum indicators remain mixed, trading volume has yet to surge meaningfully. The current rally lacks strong continuation volume, and price remains within the highlighted zone. Any breakout above $12.97 would require sustained buying interest. Until then, the chart indicates further price compression may continue. Current price structure resembles a base-building phase, and market participants continue to monitor volatility for confirmation.

According to data from Coincodex, In 2025, Injective (INJ) is anticipated to change hands in a trading channel between $ 10.23 and $ 13.84, leading to an average annualized price of $ 11.46. This could result in a potential return on investment of 29.21% compared to the current rates.